Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
Finch Therapeutics Group, Inc.
See All Filings
|
D | 2018-03-05 14:48:04 |
Amount To Be Raised
$36,399,996
Associated Brokers / Dealers
N/A
CIK Number
0001733257
Filed Document
0001733257-18-000001
Exclusions or Exemptions
506c
Accepted Date
2018-03-05 14:48:04
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Finch Therapeutics Group, Inc.
See All Filings
|
D | 2019-05-20 10:58:16 |
Amount To Be Raised
$22,999,996
Associated Brokers / Dealers
N/A
CIK Number
0001733257
Filed Document
0001733257-19-000001
Exclusions or Exemptions
506b
Accepted Date
2019-05-20 10:58:16
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Finch Therapeutics Group, Inc.
See All Filings
|
D | 2020-09-17 15:54:04 |
Amount To Be Raised
$90,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001733257
Filed Document
0001733257-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-09-17 15:54:04
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Finch Therapeutics Group, Inc.
See All Filings
|
D/A | 2020-09-23 15:39:10 |
Amount To Be Raised
$90,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001733257
Filed Document
0001733257-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-09-23 15:39:10
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Finch Therapeutics Group, Inc.
See All Filings
|
D/A | 2019-07-19 11:08:27 |
Amount To Be Raised
$53,465,316
Associated Brokers / Dealers
N/A
CIK Number
0001733257
Filed Document
0001733257-19-000002
Exclusions or Exemptions
506b
Accepted Date
2019-07-19 11:08:27
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|